In addition to a Covid-19 vaccine, we also need a trusted plan for it – STAT
The exciting progress being made in developing Covid-19 vaccines must be matched by a trusted plan for distributing and administering them.
The exciting progress being made in developing Covid-19 vaccines must be matched by a trusted plan for distributing and administering them.
Join STAT’s leading DC bureau as they take the stage with policymakers, patient advocates, and industry experts to discuss the biggest issues in health policy…
For miners and other stone cutters, silica is a serious health hazard. New rules announced on Tuesday set strict limits on how much of the…
Eli Lilly reported Wednesday that the GLP-1 drug cut breathing interruptions in obese or overweight patients experiencing the condition.
“It was very much about following the algorithms and basically not using your clinical judgment,” one former NaviHealth medical reviewer said. “That was very different…
A new study shows that high physician empathy could offer patients with lower back pain lasting benefits.
Amylyx’s data on its ALS drug, Relvyvrio, was, as promised, disappointing.
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
Millions of children are coming of age in an unrestricted and unprotected digital universe. They need guardrails that can keep them safe.
The lawmakers’ questions Tuesday offered a window into what actions Congress could take in response to the unprecedented Change cyberattack.
UnitedHealth reaffirmed its financial outlook despite up to a $1.6 billion hit from the Change Healthcare cyberattack.